EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effects of patent foramen ovale in migraine: a metabolomics‐based study

Bosi Dong iD, Xin Li iD, Lu Zhang, Ge Liang, Wen Zheng, Luolan Gui, Shuming Ji, Yusha Tang, Hua Li, Wanling Li, Ruiqi Yang, Yajiao Li und 4 weitere

The Journal of Physiology · 2025-02 · 603 (4) · 809-835

DOI: 10.1113/jp286772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, online erschienen am 21.01.2025. Verfasst von Bosi Dong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Migraine Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), SCU | West China Hospital, Sichuan University (WCH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patent foramen ovale (PFO), a cardiac anatomical anomaly inducing abnormal haemodynamics, leads to a paradoxical bypass of the pulmonary circulation. PFO closure might alleviate migraines; however, clinical evidence and basic experiments for the relationship are lacking. To explore the effect of PFO on migraine, 371 migraineurs finishing blood tests and contrast transthoracic echocardiography for the detection of PFO were prospectively included. Multivariate regression analysis revealed that PFO was independently associated with aura, and lower cystatin‐C (cys‐C) and calcium levels. Among them, patients with PFO who underwent percutaneous PFO closure were continuously followed up 1 year after the operation. The intensity of migraine was significantly relieved and the levels of cys‐C and calcium increased after PFO closure. Untargeted and targeted metabolomics of plasma from migraineurs before and after PFO closure revealed that 5‐HT and glutathione (GSH) metabolites were differentially expressed after PFO closure. The differential metabolites were then validated in the plasma and brain tissues of PFO mouse models by LC‐MS/MS analysis. Desorption electrospray ionization mass imaging demonstrated that these metabolic alterations occurred mainly in the posterior cerebral cortex. Collectively, aura, cys‐C and calcium could be biomarkers of migraineurs with PFO. PFO might have an impact on the posterior head associated with the regulation of 5‐HT and GSH. PFO closure might relieve migraine by improving 5‐HT clearance metabolism and ameliorating redox reactions. Our results may provide evidence for an indication of PFO closure in migraine and support the related potential mechanism. image Key points Aura, and levels of cystatin‐C and calcium are biomarkers of migraineurs with a patent foramen ovale (PFO). The clearance of pulmonary metabolism of 5‐HT and deoxygenated blood might be the reason for the improvement of migraine symptoms in patients with PFO. The posterior region of the brain is the main area responsible for PFO‐induced migraine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Foramen Ovale, PatentMigraine DisordersHumansMaleFemaleAnimalsAdultMetabolomicsMiddle AgedMiceCalciumSerotoninCystatin CGlutathioneBiomarkers

Stichwörter der Autor:innen

metabolomicsmigraineneurocardiologypatent foramen ovale

Substanzen

CalciumSerotoninCystatin CGlutathioneBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Clinical Proteomics and Metabolomics, Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, National Clinical Research Center for Geriatrics, West China Hospital,…
  • Core Facilities of West China Hospital, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Bosi Dong, Xin Li, Lei Chen

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • SCU | West China Hospital, Sichuan University (WCH)

Zitieren

APA

Dong, B., Li, X., Zhang, L., Liang, G., Zheng, W., Gui, L., Ji, S., Tang, Y., Li, H., Li, W., Yang, R., Li, Y., Peng, A., Chen, Y., Gong, M., & Chen, L. (2025). Effects of patent foramen ovale in migraine: a metabolomics‐based study. The Journal of Physiology, 603(4), 809-835. https://doi.org/10.1113/jp286772

Vancouver

Dong B, Li X, Zhang L, Liang G, Zheng W, Gui L, et al. Effects of patent foramen ovale in migraine: a metabolomics‐based study. The Journal of Physiology. 2025;603(4):809-835. doi:10.1113/jp286772

BibTeX
@article{Dong2025,
  author = {Dong, Bosi and Li, Xin and Zhang, Lu and Liang, Ge and Zheng, Wen and Gui, Luolan and Ji, Shuming and Tang, Yusha and Li, Hua and Li, Wanling and Yang, Ruiqi and Li, Yajiao and Peng, Anjiao and Chen, Yucheng and Gong, Meng and Chen, Lei},
  title = {Effects of patent foramen ovale in migraine: a metabolomics‐based study},
  journal = {The Journal of Physiology},
  year = {2025},
  volume = {603},
  number = {4},
  pages = {809--835},
  doi = {10.1113/jp286772}
}
Kostenlos starten →